feedzop-word-mark-logo
searchLogin
Feedzop
homeFor YouUnited StatesUnited States
You
bookmarksYour BookmarkshashtagYour Topics
Trending
trending

Powerball jackpot nears $593 million

trending

Sunrise on the Reaping trailer

trending

Olympian snowboarder drug trafficking charges

trending

Taylor Swift ARIA win divisive

trending

Nvidia lifts stock market today

trending

Jelly Roll shaves beard

trending

Miss Universe 2025 controversy

trending

Severe thunderstorm warning: Phoenix

trending

Amazon Prime refunds issued

Terms of UsePrivacy PolicyAboutJobsPartner With Us

© 2025 Advergame Technologies Pvt. Ltd. ("ATPL"). Gamezop ® & Quizzop ® are registered trademarks of ATPL.

Gamezop is a plug-and-play gaming platform that any app or website can integrate to bring casual gaming for its users. Gamezop also operates Quizzop, a quizzing platform, that digital products can add as a trivia section.

Over 5,000 products from more than 70 countries have integrated Gamezop and Quizzop. These include Amazon, Samsung Internet, Snap, Tata Play, AccuWeather, Paytm, Gulf News, and Branch.

Games and trivia increase user engagement significantly within all kinds of apps and websites, besides opening a new stream of advertising revenue. Gamezop and Quizzop take 30 minutes to integrate and can be used for free: both by the products integrating them and end users

Increase ad revenue and engagement on your app / website with games, quizzes, astrology, and cricket content. Visit: business.gamezop.com

Property Code: 5571

Home / Health / E. coli Cheese Recall: Highest FDA Risk Warning Issued

E. coli Cheese Recall: Highest FDA Risk Warning Issued

20 Nov

•

Summary

  • Two Washington companies recalled cheese due to E. coli risk.
  • FDA issued its highest Class I risk warning for the recalled cheese.
  • At least three E. coli O103 cases reported in Oregon and Washington.
E. coli Cheese Recall: Highest FDA Risk Warning Issued

Twin Sisters Creamery and The Peterson Company in Washington are facing a voluntary recall of cheese products due to potential contamination with Shiga toxin-producing E. coli (STEC) and E. coli O103. The U.S. Food and Drug Administration (FDA) has classified these recalls as Class I, its most serious risk category, signaling a significant threat to public health. This classification means there is a high probability that consuming the affected products could lead to severe health consequences or even death.

The recalls began on October 25, with Twin Sisters Creamery initiating its own voluntary recall. The Peterson Company followed suit the next day, recalling Twin Sisters Creamery-branded products. As of the article's reporting, at least three cases of STEC infection caused by E. coli O103 have been identified in Oregon and Washington. One reported instance involved a person in Oregon who consumed Twin Sisters Creamery Farmhouse cheese before falling ill.

E. coli infections remain a significant public health issue in the United States, with millions of illnesses, hospitalizations, and deaths attributed to various strains annually. The FDA's Class I recall underscores the severity of this particular contamination event, urging consumers to be aware of the identified batch codes associated with the recalled cheese products. Twin Sisters Creamery has stated that no cheese from their brand is currently available for sale or shipping.

Disclaimer: This story has been auto-aggregated and auto-summarised by a computer program. This story has not been edited or created by the Feedzop team.
Twin Sisters Creamery and Peterson Company have recalled various cheese products made from raw, unpasteurized milk and aged over 60 days.
The FDA issued a Class I recall because the cheese is potentially contaminated with E. coli, posing a serious health risk.
At least three cases of E. coli O103 infection have been reported in Oregon and Washington, with one case linked to Twin Sisters Creamery cheese.

Read more news on

Healthside-arrow

You may also like

Jeni's Recalls Ice Cream Bars Over Soy/Wheat

19 Nov • 4 reads

article image

Microbiome Therapy Promises 77% Reduction in Newborn Food Allergies

18 Nov • 16 reads

article image

FDA Approves Sarepta's Elevidys with New Safety Warnings for DMD Treatment

17 Nov • 20 reads

article image

FDA Approves Rare Leukemia Pill Komzifti, Faces Boxed Warning

14 Nov • 36 reads

Biocon Cuts Biosimilar Costs by 50% as US Eases Testing Rules

13 Nov • 44 reads

article image